1. Home
  2. HRTX
  3. HRTX News

Latest Heron Therapeutics Inc. (HRTX) News on June 22, 2025

HRTX

MT Newswires

13 days ago

HC Wainwright Initiates Coverage on Heron Therapeutics With Buy Rating, $6 Price Target

Ulta Stock Jumps as Beauty Product Spending Continues
HRTX

Investopedia

23 days ago

Ulta Stock Jumps as Beauty Product Spending Continues

Drone Light Show Market to Soar to $5 Billion by 2034, Fueled by 13% CAGR and Rising Demand for Innovative Entertainment | Exactitude Consultancy
HRTX

GlobeNewswire

23 days ago

Drone Light Show Market to Soar to $5 Billion by 2034, Fueled by 13% CAGR and Rising Demand for Innovative Entertainment | Exactitude Consultancy

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy
HRTX

GlobeNewswire

23 days ago

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy

Northrop Grumman Raises $1 Billion Via Debt
HRTX

Benzinga

23 days ago

Northrop Grumman Raises $1 Billion Via Debt

Spinosad Active Ingredient Market Set for Steady Growth, Driven by Sustainable Farming Trends | Exactitude Consultancy
HRTX

GlobeNewswire

23 days ago

Spinosad Active Ingredient Market Set for Steady Growth, Driven by Sustainable Farming Trends | Exactitude Consultancy

HRTX

Newsfile

23 days ago

Max Resource Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

TEN, Ltd. Announces Date for the First Quarter 2025 Results, Conference Call and Webcast
HRTX

GlobeNewswire

23 days ago

TEN, Ltd. Announces Date for the First Quarter 2025 Results, Conference Call and Webcast

The York Water Company Files a Rate Request Based on $145 Million in Investment
HRTX

GlobeNewswire

23 days ago

The York Water Company Files a Rate Request Based on $145 Million in Investment

Results: Heron Therapeutics, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
HRTX

Simply Wall St.

a month ago

Results: Heron Therapeutics, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Heron Therapeutics First Quarter 2025 Earnings: Beats Expectations
HRTX

Simply Wall St.

a month ago

Heron Therapeutics First Quarter 2025 Earnings: Beats Expectations

HRTX

GuruFocus.com

a month ago

Heron Therapeutics Inc (HRTX) Q1 2025 Earnings Call Highlights: Record EBITDA and Significant ...

HRTX

MT Newswires

2 months ago

Heron Settles Patent Litigation With Mylan Over Cinvanti, Aponvie; Shares Rise

Compared to Estimates, Heron Therapeutics (HRTX) Q1 Earnings: A Look at Key Metrics
HRTX

Zacks

2 months ago

Compared to Estimates, Heron Therapeutics (HRTX) Q1 Earnings: A Look at Key Metrics

Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates
HRTX

Zacks

2 months ago

Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates

HRTX

Associated Press Finance

2 months ago

Heron Therapeutics: Q1 Earnings Snapshot

Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates
HRTX

PR Newswire

2 months ago

Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates

Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations
HRTX

PR Newswire

2 months ago

Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations

Akebia Therapeutics (AKBA) Expected to Beat Earnings Estimates: Should You Buy?
HRTX

Zacks

2 months ago

Akebia Therapeutics (AKBA) Expected to Beat Earnings Estimates: Should You Buy?

Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
HRTX

Zacks

2 months ago

Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

HRTX

MT Newswires

2 months ago

Heron Therapeutics Names Mark Hensley as COO

Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer
HRTX

PR Newswire

2 months ago

Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics
HRTX

Zacks

2 months ago

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics

5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms
HRTX

Zacks

2 months ago

5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
HRTX

Zacks

2 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025
HRTX

PR Newswire

2 months ago

Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025

Best Momentum Stocks to Buy for April 22nd
HRTX

Zacks

2 months ago

Best Momentum Stocks to Buy for April 22nd

Are Medical Stocks Lagging Encompass Health (EHC) This Year?
HRTX

Zacks

2 months ago

Are Medical Stocks Lagging Encompass Health (EHC) This Year?

Exploring High Growth Tech Stocks In The US Market April 2025
HRTX

Simply Wall St.

3 months ago

Exploring High Growth Tech Stocks In The US Market April 2025

Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected To Breakeven In The Medium-Term
HRTX

Simply Wall St.

3 months ago

Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected To Breakeven In The Medium-Term

Is Heron Therapeutics, Inc. (HRTX) The Hot Biotech Stock Under $5?
HRTX

Insider Monkey

3 months ago

Is Heron Therapeutics, Inc. (HRTX) The Hot Biotech Stock Under $5?

Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported Earnings, And Analysts Cut Their Target Price
HRTX

Simply Wall St.

4 months ago

Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported Earnings, And Analysts Cut Their Target Price

High Growth Tech Stocks to Watch in US Market February 2025
HRTX

Simply Wall St.

4 months ago

High Growth Tech Stocks to Watch in US Market February 2025

Heron Therapeutics (NASDAQ:HRTX) shareholders are up 19% this past week, but still in the red over the last five years
HRTX

Simply Wall St.

4 months ago

Heron Therapeutics (NASDAQ:HRTX) shareholders are up 19% this past week, but still in the red over the last five years

Heron Therapeutics Full Year 2024 Earnings: Beats Expectations
HRTX

Simply Wall St.

4 months ago

Heron Therapeutics Full Year 2024 Earnings: Beats Expectations

HRTX

GuruFocus.com

4 months ago

Heron Therapeutics Inc (HRTX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

HRTX

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Heron Therapeutics Inc Earnings Call

Heron Therapeutics (HRTX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
HRTX

Zacks

4 months ago

Heron Therapeutics (HRTX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

HRTX

Associated Press Finance

4 months ago

Heron Therapeutics: Q4 Earnings Snapshot

Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates
HRTX

PR Newswire

4 months ago

Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates

Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025
HRTX

PR Newswire

4 months ago

Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) is a favorite amongst institutional investors who own 58%
HRTX

Simply Wall St.

5 months ago

Heron Therapeutics, Inc. (NASDAQ:HRTX) is a favorite amongst institutional investors who own 58%

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina
HRTX

PR Newswire

6 months ago

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina

Exploring Three High Growth Tech Stocks In The United States
HRTX

Simply Wall St.

6 months ago

Exploring Three High Growth Tech Stocks In The United States

HRTX

MT Newswires

7 months ago

Top Premarket Gainers

HRTX

MT Newswires

7 months ago

Update: Heron Therapeutics Shares Surge Premarket Following Favorable Cinvanti Patent Ruling

HRTX

MT Newswires

7 months ago

Heron Therapeutics Shares Surge on Favorable Cinvanti Patent Ruling

U.S. District Court Upholds Validity of CINVANTI® Patents
HRTX

PR Newswire

7 months ago

U.S. District Court Upholds Validity of CINVANTI® Patents

HRTX

GuruFocus.com

7 months ago

Heron Therapeutics Inc (HRTX) Q3 2024 Earnings Call Highlights: Strategic Initiatives Drive ...

Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
HRTX

Zacks

7 months ago

Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates
HRTX

Zacks

7 months ago

Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates

HRTX

Associated Press Finance

7 months ago

Heron Therapeutics: Q3 Earnings Snapshot

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance
HRTX

PR Newswire

7 months ago

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance

Unveiling Heron Therapeutics (HRTX) Q3 Outlook: Wall Street Estimates for Key Metrics
HRTX

Zacks

7 months ago

Unveiling Heron Therapeutics (HRTX) Q3 Outlook: Wall Street Estimates for Key Metrics

Positive Signs As Multiple Insiders Buy Heron Therapeutics Stock
HRTX

Simply Wall St.

8 months ago

Positive Signs As Multiple Insiders Buy Heron Therapeutics Stock

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors
HRTX

PR Newswire

8 months ago

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors

Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?
HRTX

Zacks

8 months ago

Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?

Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024
HRTX

PR Newswire

8 months ago

Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024

HRTX

MT Newswires

8 months ago

Heron Therapeutics Reaffirms Supply of Ready-to-Administer Nausea Prevention Medications

Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids
HRTX

PR Newswire

8 months ago

Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability
HRTX

Simply Wall St.

9 months ago

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability

HRTX

MT Newswires

9 months ago

Heron Therapeutics Receives FDA Approval for Zynrelef Extended-Release Solution

Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")
HRTX

PR Newswire

9 months ago

Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")

Exploring Three High Growth Tech Stocks in the United States
HRTX

Simply Wall St.

9 months ago

Exploring Three High Growth Tech Stocks in the United States

Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer
HRTX

PR Newswire

10 months ago

Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer

Heron Therapeutics Second Quarter 2024 Earnings: EPS Misses Expectations
HRTX

Simply Wall St.

10 months ago

Heron Therapeutics Second Quarter 2024 Earnings: EPS Misses Expectations

Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
HRTX

Zacks

10 months ago

Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates
HRTX

Zacks

10 months ago

Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates

HRTX

Associated Press Finance

10 months ago

Heron Therapeutics: Q2 Earnings Snapshot

Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance
HRTX

PR Newswire

10 months ago

Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance

Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024
HRTX

PR Newswire

a year ago

Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024

While shareholders of Heron Therapeutics (NASDAQ:HRTX) are in the black over 1 year, those who bought a week ago aren't so fortunate
HRTX

Simply Wall St.

a year ago

While shareholders of Heron Therapeutics (NASDAQ:HRTX) are in the black over 1 year, those who bought a week ago aren't so fortunate

HRTX

MT Newswires

a year ago

Heron Therapeutics Says Non-Opioid Pain Medication to be Included in Proposed Medicare Programs

Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System
HRTX

PR Newswire

a year ago

Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System

Heron Therapeutics (HRTX) Upgraded to Strong Buy: Here's What You Should Know
HRTX

Zacks

a year ago

Heron Therapeutics (HRTX) Upgraded to Strong Buy: Here's What You Should Know

Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View
HRTX

Zacks

a year ago

Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View

HRTX

MT Newswires

a year ago

Heron Reports Acceptance of Prior Approval Supplement Application for Zynrelef Vial Access Needle

Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
HRTX

Zacks

a year ago

Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner

Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")
HRTX

PR Newswire

a year ago

Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")

With 55% ownership of the shares, Heron Therapeutics, Inc. (NASDAQ:HRTX) is heavily dominated by institutional owners
HRTX

Simply Wall St.

a year ago

With 55% ownership of the shares, Heron Therapeutics, Inc. (NASDAQ:HRTX) is heavily dominated by institutional owners

Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock?
HRTX

Zacks

a year ago

Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock?

Avidity (RNA) Up 33% on Rare Muscle Disease Study Results
HRTX

Zacks

a year ago

Avidity (RNA) Up 33% on Rare Muscle Disease Study Results

FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
HRTX

Zacks

a year ago

FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D

HRTX

MT Newswires

a year ago

Connect Biopharma Names New Chief Executive, Chair

Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
HRTX

Zacks

a year ago

Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
HRTX

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

HRTX

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
HRTX

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

HRTX

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
HRTX

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
HRTX

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
HRTX

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research
HRTX

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease
HRTX

Zacks

a year ago

Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease

Eli Lilly (LLY) Veteran Anat Ashkenazi to Join Alphabet as CFO
HRTX

Zacks

a year ago

Eli Lilly (LLY) Veteran Anat Ashkenazi to Join Alphabet as CFO

Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
HRTX

Zacks

a year ago

Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms
HRTX

Zacks

a year ago

J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms

Merck (MRK) to Buy Private Ophthalmology Company EyeBio
HRTX

Zacks

a year ago

Merck (MRK) to Buy Private Ophthalmology Company EyeBio

Pleasing Signs As A Number Of Insiders Buy Heron Therapeutics Stock
HRTX

Simply Wall St.

a year ago

Pleasing Signs As A Number Of Insiders Buy Heron Therapeutics Stock

Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
HRTX

Zacks

a year ago

Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data

Share on Social Networks: